Literature DB >> 24396026

Interferon regulatory factors in heart: stress response beyond inflammation.

Haipeng Sun1, Yibin Wang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24396026      PMCID： PMC4046326          DOI： 10.1161/HYPERTENSIONAHA.113.02795

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  14 in total

1.  Interferon-γ ablation exacerbates myocardial hypertrophy in diastolic heart failure.

Authors:  Anthony G Garcia; Richard M Wilson; Joline Heo; Namita R Murthy; Simoni Baid; Noriyuki Ouchi; Flora Sam
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-06-22       Impact factor: 4.733

2.  Recombinant alpha 2 interferon-related cardiomyopathy.

Authors:  M C Cohen; M S Huberman; R W Nesto
Journal:  Am J Med       Date:  1988-10       Impact factor: 4.965

3.  Interferon regulatory factor 7 functions as a novel negative regulator of pathological cardiac hypertrophy.

Authors:  Ding-Sheng Jiang; Yu Liu; Heng Zhou; Yan Zhang; Xiao-Dong Zhang; Xiao-Fei Zhang; Ke Chen; Lu Gao; Juan Peng; Hui Gong; Yingjie Chen; Qinglin Yang; Peter P Liu; Guo-Chang Fan; Yunzeng Zou; Hongliang Li
Journal:  Hypertension       Date:  2014-01-06       Impact factor: 10.190

4.  Role of interferon regulatory factor 4 in the regulation of pathological cardiac hypertrophy.

Authors:  Ding-Sheng Jiang; Zhou-Yan Bian; Yan Zhang; Shu-Min Zhang; Yi Liu; Rui Zhang; Yingjie Chen; Qinglin Yang; Xiao-Dong Zhang; Guo-Chang Fan; Hongliang Li
Journal:  Hypertension       Date:  2013-04-15       Impact factor: 10.190

Review 5.  Review article: investigational agents for chronic hepatitis C.

Authors:  A J V Thompson; J G McHutchison
Journal:  Aliment Pharmacol Ther       Date:  2009-01-17       Impact factor: 8.171

6.  Interferon-γ signaling inhibition ameliorates angiotensin II-induced cardiac damage.

Authors:  Lajos Markó; Heda Kvakan; Joon-Keun Park; Fatimunnisa Qadri; Bastian Spallek; Katrina J Binger; Edward P Bowman; Markus Kleinewietfeld; Verena Fokuhl; Ralf Dechend; Dominik N Müller
Journal:  Hypertension       Date:  2012-10-29       Impact factor: 10.190

7.  Interferon-gamma induces chronic active myocarditis and cardiomyopathy in transgenic mice.

Authors:  Kurt Reifenberg; Hans-Anton Lehr; Michael Torzewski; Gisela Steige; Elena Wiese; Ines Küpper; Christoph Becker; Sibylle Ott; Petra Nusser; Ken-Ichi Yamamura; Gerd Rechtsteiner; Tobias Warger; Andrea Pautz; Hartmut Kleinert; Albrecht Schmidt; Burkert Pieske; Philip Wenzel; Thomas Münzel; Jürgen Löhler
Journal:  Am J Pathol       Date:  2007-06-07       Impact factor: 4.307

8.  Interferon regulatory factor 9 protects against cardiac hypertrophy by targeting myocardin.

Authors:  Ding-Sheng Jiang; Yu-Xuan Luo; Ran Zhang; Xiao-Dong Zhang; Hou-Zao Chen; Yan Zhang; Ke Chen; Shu-Min Zhang; Guo-Chang Fan; Peter P Liu; De-Pei Liu; Hongliang Li
Journal:  Hypertension       Date:  2013-10-21       Impact factor: 10.190

9.  Interferon regulatory factor 3 is a negative regulator of pathological cardiac hypertrophy.

Authors:  Jing Lu; Zhou-Yan Bian; Ran Zhang; Yan Zhang; Chen Liu; Ling Yan; Shu-Min Zhang; Ding-Sheng Jiang; Xiang Wei; Xue Hai Zhu; Manyin Chen; Ai-Bing Wang; Yingjie Chen; Qinglin Yang; Peter P Liu; Hongliang Li
Journal:  Basic Res Cardiol       Date:  2013-01-11       Impact factor: 17.165

Review 10.  Transcription factors in heart: promising therapeutic targets in cardiac hypertrophy.

Authors:  Shrey Kohli; Suchit Ahuja; Vibha Rani
Journal:  Curr Cardiol Rev       Date:  2011-11
View more
  6 in total

Review 1.  Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular disease.

Authors:  Malgorzata Szelag; Anna Piaszyk-Borychowska; Martyna Plens-Galaska; Joanna Wesoly; Hans A R Bluyssen
Journal:  Oncotarget       Date:  2016-07-26

2.  Aronia berry extract inhibits TNF-α-induced vascular endothelial inflammation through the regulation of STAT3.

Authors:  Tomomi Iwashima; Yuki Kudome; Yoshimi Kishimoto; Emi Saita; Miori Tanaka; Chie Taguchi; Satoshi Hirakawa; Nobu Mitani; Kazuo Kondo; Kaoruko Iida
Journal:  Food Nutr Res       Date:  2019-08-16       Impact factor: 3.894

Review 3.  Regulation of Type 2 Immunity in Myocardial Infarction.

Authors:  Jun-Yan Xu; Yu-Yan Xiong; Xiao-Tong Lu; Yue-Jin Yang
Journal:  Front Immunol       Date:  2019-01-29       Impact factor: 7.561

4.  Circulating proteomic signature of early death in heart failure patients with reduced ejection fraction.

Authors:  Marie Cuvelliez; Vincent Vandewalle; Maxime Brunin; Olivia Beseme; Audrey Hulot; Pascal de Groote; Philippe Amouyel; Christophe Bauters; Guillemette Marot; Florence Pinet
Journal:  Sci Rep       Date:  2019-12-16       Impact factor: 4.379

5.  Genome-Wide Inhibition of Pro-atherogenic Gene Expression by Multi-STAT Targeting Compounds as a Novel Treatment Strategy of CVDs.

Authors:  Martyna Plens-Galaska; Malgorzata Szelag; Aida Collado; Patrice Marques; Susana Vallejo; Mariella Ramos-González; Joanna Wesoly; María Jesus Sanz; Concepción Peiró; Hans A R Bluyssen
Journal:  Front Immunol       Date:  2018-09-19       Impact factor: 7.561

6.  Impact of a diet and activity health promotion intervention on regional patterns of DNA methylation.

Authors:  Elizabeth Hibler; Lei Huang; Jorge Andrade; Bonnie Spring
Journal:  Clin Epigenetics       Date:  2019-09-11       Impact factor: 6.551
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.